-
1دورية أكاديمية
المؤلفون: Lacey L; LaceySolutions Ltd, Dublin, Ireland. larryflacey@utvinternet.com, Chien RN, Chuang WL, Pwu RF
المصدر: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2008 Apr; Vol. 23 (4), pp. 571-9.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: Australia NLM ID: 8607909 Publication Model: Print Cited Medium: Internet ISSN: 1440-1746 (Electronic) Linking ISSN: 08159319 NLM ISO Abbreviation: J Gastroenterol Hepatol Subsets: MEDLINE
مواضيع طبية MeSH: Adenine/*analogs & derivatives , Antiviral Agents/*economics , Antiviral Agents/*therapeutic use , Hepatitis B, Chronic/*drug therapy , Hepatitis B, Chronic/*economics , Lamivudine/*economics , Lamivudine/*therapeutic use , Organophosphonates/*economics , Organophosphonates/*therapeutic use, Adenine/economics ; Adenine/therapeutic use ; Adult ; Cost-Benefit Analysis ; Female ; Humans ; Male ; Taiwan ; Time Factors
-
2دورية أكاديمية
المؤلفون: Tseng PL; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan., Lu SN, Tung HD, Wang JH, Changchien CS, Lee CM
المصدر: Journal of viral hepatitis [J Viral Hepat] 2005 Jul; Vol. 12 (4), pp. 386-92.
نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9435672 Publication Model: Print Cited Medium: Print ISSN: 1352-0504 (Print) Linking ISSN: 13520504 NLM ISO Abbreviation: J Viral Hepat Subsets: MEDLINE
مواضيع طبية MeSH: Antiviral Agents/*therapeutic use , Hepatitis B, Chronic/*drug therapy , Lamivudine/*therapeutic use , Liver Cirrhosis/*drug therapy, Adenine/analogs & derivatives ; Adenine/therapeutic use ; Adult ; Aged ; Drug Resistance, Viral/genetics ; Female ; Hepatic Encephalopathy ; Hepatitis B virus/drug effects ; Hepatitis B virus/genetics ; Hepatitis B virus/isolation & purification ; Hepatitis B, Chronic/complications ; Humans ; Liver Cirrhosis/mortality ; Liver Cirrhosis/virology ; Male ; Middle Aged ; Mutation ; Organophosphonates/therapeutic use ; Survival Analysis ; Taiwan